Liver Open Access Journals
The liver is an organ about the dimensions of a football. It sits slightly below your skeletal structure on the proper side of your abdomen. The liver is important for digesting food and ridding your body of toxic substances. Liver disease can be inherited (genetic). Liver problems also can be caused by a spread of things that damage the liver, like viruses, alcohol use and obesity. Over time, conditions that damage the liver can cause scarring (cirrhosis), which may cause liver failure, a life-threatening condition. At starting state the treatment may give the liver time to heal. Liver disease doesn't always cause noticeable signs and symptoms. If signs and symptoms of disease do occur, the may include: Skin and eyes that appear yellowish (jaundice), Abdominal pain and swelling, Swelling in the legs and ankles, Itchy skin, Dark urine color. It likewise produces an expected 800 to 1,000 milliliters Trusted Source of bile daily. This bile is shipped by means of a bile pipe to the small digestive system. The small digestive tract utilizes the bile to additionally separate fats. Any additional bile is put away in the gallbladder. The liver separates proteins too. The result of this procedure is called smelling salts, which can be harmful to the body in huge sums. The liver transforms the poisonous smelling salts into a substance called urea.
High Impact List of Articles
-
Dextromethorphan/quinidine for pseudobulbar affect
Steven L Dubovsky
Review: Clinical Trail Outcomes: Clinical Investigation
-
Dextromethorphan/quinidine for pseudobulbar affect
Steven L Dubovsky
Review: Clinical Trail Outcomes: Clinical Investigation
-
How important are willingness to participate studies in encouraging patient enrollment in oncology trials?
Anand Shah
Editorial: Clinical Investigation
-
How important are willingness to participate studies in encouraging patient enrollment in oncology trials?
Anand Shah
Editorial: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
New strategies for the treatment of inflammatory bowel diseases
Xavier Roblin, William Dronne, Stephane Paul, Emilie Del Tedesco
Review: Clinical Trail Outcomes: Clinical Investigation
-
New strategies for the treatment of inflammatory bowel diseases
Xavier Roblin, William Dronne, Stephane Paul, Emilie Del Tedesco
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of eribulin mesylate in the treatment of breast cancer
Carole Gourmelon, Jean Sebastien Frenel,Mario Campone
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of eribulin mesylate in the treatment of breast cancer
Carole Gourmelon, Jean Sebastien Frenel,Mario Campone
Review: Clinical Trail Outcomes: Clinical Investigation
Relevant Topics in Clinical